価格表

在庫・価格 : 2024年03月28日 18時54分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
GW 9662
データシート
70785 CAYケイマン ケミカル
Cayman Chemical Company
1 mg ¥2,700
(未発注)
追加

在庫・価格 : 2024年03月28日 18時54分 現在

GW 9662

  • 商品コード:70785
  • メーカー:CAY
  • 包装:1mg
  • 価格: ¥2,700
  • 在庫:無(未発注)
参考文献
No. 文献情報 備考 参照
1 Wright HM et al. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. J. Biol. Chem. 2000 Jan;275(3):1873-7
Wright HM et al
2000/01/01
PubMed
2 Maxey KM et al. The nature and composition of 15-deoxy-Delta(12,14)PGJ(2). Prostaglandins Other Lipid Mediat. 2000 Jun;62(1):15-21
Maxey KM et al
2000/01/01
PubMed
3 Bendixen AC et al. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc. Natl. Acad. Sci. U.S.A. 2001 Feb;98(5):2443-8
Bendixen AC et al
2001/01/01
PubMed
4 Davies SS et al. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J. Biol. Chem. 2001 May;276(19):16015-23
Davies SS et al
2001/01/01
PubMed
5 Lehmann JM et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 1995 Jun;270(22):12953-6
Lehmann JM et al
1995/01/01
PubMed
6 Cantello BC et al. [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents. J. Med. Chem. 1994 Nov;37(23):3977-85
Cantello BC et al
1994/01/01
PubMed
7 Willson TM et al. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 1996 Feb;39(3):665-8
Willson TM et al
1996/01/01
PubMed
  • No.: 1
  • 文献情報:
    Wright HM et al. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation. J. Biol. Chem. 2000 Jan;275(3):1873-7
    Wright HM et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Maxey KM et al. The nature and composition of 15-deoxy-Delta(12,14)PGJ(2). Prostaglandins Other Lipid Mediat. 2000 Jun;62(1):15-21
    Maxey KM et al
    2000/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Bendixen AC et al. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1. Proc. Natl. Acad. Sci. U.S.A. 2001 Feb;98(5):2443-8
    Bendixen AC et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Davies SS et al. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists. J. Biol. Chem. 2001 May;276(19):16015-23
    Davies SS et al
    2001/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Lehmann JM et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 1995 Jun;270(22):12953-6
    Lehmann JM et al
    1995/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Cantello BC et al. [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents. J. Med. Chem. 1994 Nov;37(23):3977-85
    Cantello BC et al
    1994/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Willson TM et al. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 1996 Feb;39(3):665-8
    Willson TM et al
    1996/01/01
  • 備考:
  • 参照:
    PubMed